Literature DB >> 15832305

Genomic rearrangements in the BRCA1 and BRCA2 genes.

Sylvie Mazoyer1.   

Abstract

Mutations in the BRCA1 and BRCA2 genes predispose women to breast and ovarian cancer. BRCA1 and BRCA2 are 83 and 86 kb long, with coding sequences of 5.7 and 10.2 kb, scattered over 22 and 26 coding exons, respectively. The large majority of the alterations identified in these genes are point mutations and small insertions/deletions. However, an increasing number of large genomic rearrangements are being identified, especially in BRCA1. This review gives a brief overview of the techniques used to screen the BRCA1 and BRCA2 genes for large rearrangements, and describes those for which the breakpoints have been characterized. The principal mechanisms that are thought to lead to their formation, founder effects, and recombination hotspots, are also discussed.

Entities:  

Mesh:

Year:  2005        PMID: 15832305     DOI: 10.1002/humu.20169

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  50 in total

1.  BRCA1 and BRCA2 mutations and treatment strategies for breast cancer.

Authors:  Inês Godet; Daniele M Gilkes
Journal:  Integr Cancer Sci Ther       Date:  2017-02-27

2.  Large genomic rearrangement of BRCA1 and BRCA2 genes in familial breast cancer patients in Korea.

Authors:  Ja Young Cho; Dae-Yeon Cho; Sei Hyun Ahn; Su-Youn Choi; Inkyung Shin; Hyun Gyu Park; Jong Won Lee; Hee Jeong Kim; Jong Han Yu; Beom Seok Ko; Bo Kyung Ku; Byung Ho Son
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

3.  Screening for genomic rearrangements at BRCA1 locus in Iranian women with breast cancer using multiplex ligation-dependent probe amplification.

Authors:  Vahid R Yassaee; Babak Emamalizadeh; Mir Davood Omrani
Journal:  J Genet       Date:  2013-04       Impact factor: 1.166

4.  Comprehensive analysis of pathogenic deletion variants in Fanconi anemia genes.

Authors:  Elizabeth K Flynn; Aparna Kamat; Francis P Lach; Frank X Donovan; Danielle C Kimble; Narisu Narisu; Erica Sanborn; Farid Boulad; Stella M Davies; Alfred P Gillio; Richard E Harris; Margaret L MacMillan; John E Wagner; Agata Smogorzewska; Arleen D Auerbach; Elaine A Ostrander; Settara C Chandrasekharappa
Journal:  Hum Mutat       Date:  2014-11       Impact factor: 4.878

5.  Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family.

Authors:  Ciyu Yang; Angela G Arnold; Magan Trottier; Yukio Sonoda; Nadeem R Abu-Rustum; Oliver Zivanovic; Mark E Robson; Zsofia K Stadler; Michael F Walsh; David M Hyman; Kenneth Offit; Liying Zhang
Journal:  Breast Cancer Res Treat       Date:  2016-10-18       Impact factor: 4.872

6.  BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.

Authors:  Myong Cheol Lim; Sokbom Kang; Sang-Soo Seo; Sun-Young Kong; Bo-Yon Lee; Seon-Kyung Lee; Sang-Yoon Park
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-05       Impact factor: 4.553

7.  Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations.

Authors:  Piotr Kozlowski; Penelope Roberts; Sandra Dabora; David Franz; John Bissler; Hope Northrup; Kit Sing Au; Ross Lazarus; Dorota Domanska-Pakiela; Katarzyna Kotulska; Sergiusz Jozwiak; David J Kwiatkowski
Journal:  Hum Genet       Date:  2007-02-08       Impact factor: 4.132

Review 8.  The contribution of BRCA1 and BRCA2 to ovarian cancer.

Authors:  Susan J Ramus; Simon A Gayther
Journal:  Mol Oncol       Date:  2009-02-10       Impact factor: 6.603

9.  Analysis of BRCA1 Gene Rearrangements in Breast Carcinomas by RT-PCR and ER, PR, HER2NEU Status by IHC and HPE Correlation.

Authors:  Srivatsa Prakhya; Geetha Prakash
Journal:  J Clin Diagn Res       Date:  2012-10-15

10.  LINE dancing in the human genome: transposable elements and disease.

Authors:  Victoria P Belancio; Prescott L Deininger; Astrid M Roy-Engel
Journal:  Genome Med       Date:  2009-10-27       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.